Skip to content

QUESTCOR PHARMACEUTICALS INC

Delisted

CIK 891288fmd_165518KC8NYKDG854NW67H7R3RManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2014, 19 periods

Latest annual · FY2013

Millions
Total revenues
799
Gross profit
725
Operating income
440
Net income
293
Free cash flow
334

Latest quarter · Q2 FY2014

Millions
Total revenues
279
Gross profit
256
Operating income
148
Net income
96
Free cash flow
93
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2010 to FY2013
+90.7%

QUESTCOR PHARMACEUTICALS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2012ChangeSource
Revenue$798.9 million$509.3 million+56.9%10-K 2014-02-26 · proof
Gross profit$724.6 million$480.7 million+50.7%10-K 2014-02-26 · proof
Operating income$439.8 million$296.5 million+48.3%10-K 2014-02-26 · proof
Net income$292.6 million$197.7 million+48%10-K 2014-02-26 · proof
Cash from operating activities$337.8 million$219 million+54.2%10-K 2014-02-26 · proof
Free cash flow$334.2 million$218 million+53.3%10-K 2014-02-26 · proof
Total assets$736.4 million$252.4 million+191.7%10-K 2014-02-26 · proof
Total liabilities$337 million$90.6 million+271.9%10-K 2014-02-26 · proof
Cash and cash equivalents$175.8 million$80.6 million+118.1%10-K 2014-02-26 · proof
Total debt$15.7 million$010-K 2014-02-26 · proof
What was QUESTCOR PHARMACEUTICALS INC's revenue in fiscal 2013?
QUESTCOR PHARMACEUTICALS INC reported revenue of $798.9 million for fiscal 2013 (the year ended Dec 31, 2013), against $509.3 million the year before (+56.9%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What was QUESTCOR PHARMACEUTICALS INC's gross profit in fiscal 2013?
QUESTCOR PHARMACEUTICALS INC reported gross profit of $724.6 million for fiscal 2013 (the year ended Dec 31, 2013), against $480.7 million the year before (+50.7%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What was QUESTCOR PHARMACEUTICALS INC's operating income in fiscal 2013?
QUESTCOR PHARMACEUTICALS INC reported operating income of $439.8 million for fiscal 2013 (the year ended Dec 31, 2013), against $296.5 million the year before (+48.3%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What was QUESTCOR PHARMACEUTICALS INC's net income in fiscal 2013?
QUESTCOR PHARMACEUTICALS INC reported net income of $292.6 million for fiscal 2013 (the year ended Dec 31, 2013), against $197.7 million the year before (+48%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What was QUESTCOR PHARMACEUTICALS INC's cash from operating activities in fiscal 2013?
QUESTCOR PHARMACEUTICALS INC reported cash from operating activities of $337.8 million for fiscal 2013 (the year ended Dec 31, 2013), against $219 million the year before (+54.2%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What was QUESTCOR PHARMACEUTICALS INC's free cash flow in fiscal 2013?
QUESTCOR PHARMACEUTICALS INC reported free cash flow of $334.2 million for fiscal 2013 (the year ended Dec 31, 2013), against $218 million the year before (+53.3%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What are QUESTCOR PHARMACEUTICALS INC's total assets?
As of Dec 31, 2013, QUESTCOR PHARMACEUTICALS INC reported total assets of $736.4 million, against $252.4 million a year earlier (+191.7%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What are QUESTCOR PHARMACEUTICALS INC's total liabilities?
As of Dec 31, 2013, QUESTCOR PHARMACEUTICALS INC reported total liabilities of $337 million, against $90.6 million a year earlier (+271.9%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What are QUESTCOR PHARMACEUTICALS INC's cash and cash equivalents?
As of Dec 31, 2013, QUESTCOR PHARMACEUTICALS INC reported cash and cash equivalents of $175.8 million, against $80.6 million a year earlier (+118.1%). Source: the 10-K filed with the SEC on Feb 26, 2014. SEC
What is QUESTCOR PHARMACEUTICALS INC's total debt?
As of Dec 31, 2013, QUESTCOR PHARMACEUTICALS INC reported total debt of $15.7 million, against $0 a year earlier. Source: the 10-K filed with the SEC on Feb 26, 2014. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:891288&period_type=annual&limit=5"

Information only, not investment advice.